CHARACTERIZATION OF TRANSGENIC PIGS EXPRESSING AN ANTI-CD2 MONOCLONAL ANTIBODY. A CONTINUING QUEST FOR THE IDEAL ISLET DONOR

被引：0
|
作者：
Salvaris, Evelyn [1 ]
Thomas, Adwin [2 ]
Byrne, Nicole [2 ]
Fisicaro, Nella [1 ]
Nottle, Mark B. [3 ]
Hawthorne, Wayne J. [2 ,4 ]
Cowan, Peter J. [1 ,5 ]
机构：
[1] St Vincents Hosp, Immunol Res Ctr, Fitzroy, Vic, Australia
[2] Westmead Inst Med Res, Ctr Transplant & Renal Res, Westmead, NSW, Australia
[3] Univ Adelaide, Adelaide, SA, Australia
[4] Univ Sydney, Sydney, NSW, Australia
[5] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源：
XENOTRANSPLANTATION | 2021年 / 28卷 / 05期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
130.8
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The anti-CD2 monoclonal antibody BTI-322 generates unresponsiveness by activation-associated T cell depletion
    Xu, Y
    Simonds, DK
    Hope, JA
    Bazin, H
    Latinne, D
    Monroy, R
    White-Scharf, ME
    Schuurman, HJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (03): : 476 - 483
  • [32] Coexistence of TH1- and TH2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance
    Krieger, NR
    Most, D
    Bromberg, JS
    Holm, B
    Huie, P
    Sibley, RK
    Dafoe, DC
    Alfrey, EJ
    TRANSPLANTATION, 1996, 62 (09) : 1285 - 1292
  • [33] DIFFERENTIAL IMMUNOMODULATION BY ANTI-CD2 MONOCLONAL-ANTIBODIES OF ANTI-CD3-INDUCED T-CELL ACTIVATION - DEPENDENCE UPON THE INDIVIDUAL ANTI-CD3 MONOCLONAL-ANTIBODY USED FOR ACTIVATION
    STOHL, W
    POSNETT, DN
    CHIORAZZI, N
    CELLULAR IMMUNOLOGY, 1988, 116 (01) : 73 - 85
  • [34] Tacrolimus and anti-CD2 monoclonal antibody in adult liver transplantation (LT): 5 Years results of a prospective randomized study.
    Lerut, J
    Van Thuyne, V
    Mathys, J
    Lemaire, J
    Ciccarelli, O
    Talpe, S
    Roggen, F
    De Reyck, C
    Bazin, H
    Latinne, D
    LIVER TRANSPLANTATION, 2005, 11 (07) : C45 - C45
  • [35] Effective therapy for murine model of adult T-cell leukemia with anti-CD2 monoclonal antibody, MEDI-507.
    Zhuo, Z
    Zhang, ML
    Mandler, R
    Goldman, C
    Morris, JC
    Janick, JE
    Waldmann, TA
    BLOOD, 2002, 100 (11) : 763A - 763A
  • [36] RPA-2.10 - AN ANTI-CD2 MONOCLONAL-ANTIBODY THAT INHIBITS ALLOIMMUNE RESPONSES AND MONITORS T-CELL ACTIVATION
    AVERSA, GG
    BISHOP, GA
    SURANYI, MG
    HALL, BM
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 277 - 278
  • [37] Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro
    Binder, Christian
    Sellberg, Felix
    Cvetkovski, Filip
    Berglund, Erik
    Berglund, David
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [38] Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507
    Zhang, Z
    Zhang, ML
    Ravetch, JV
    Goldman, C
    Waldmann, TA
    BLOOD, 2003, 102 (01) : 284 - 288
  • [39] REGULATION BY ANTI-CD2 MONOCLONAL-ANTIBODY OF THE ACTIVATION OF A HUMAN T-CELL CLONE INDUCED BY ANTI-CD3 OR ANTI-T CELL-RECEPTOR ANTIBODIES
    YSSEL, H
    AUBRY, JP
    MALEFIJT, RD
    DEVRIES, JE
    SPITS, H
    JOURNAL OF IMMUNOLOGY, 1987, 139 (09): : 2850 - 2855
  • [40] PARTIAL CHARACTERIZATION OF A MINOR T-CELL SUBSET IN HUMAN PERIPHERAL-BLOOD THAT BLOCKS ANTIBODY-PRODUCTION INDUCED BY ANTI-CD2 MONOCLONAL-ANTIBODIES
    TSUNODA, T
    GRAY, JD
    HORWITZ, DA
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A192 - A192
12345